Explore the words cloud of the TASPPI project. It provides you a very rough idea of what is the project "TASPPI" about.
The following table provides information about the project.
TECHNISCHE UNIVERSITEIT EINDHOVEN
|Coordinator Country||Netherlands [NL]|
|Total cost||3˙342˙323 €|
|EC max contribution||3˙342˙323 € (100%)|
1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers)
|Duration (year-month-day)||from 2016-02-01 to 2020-01-31|
Take a look of project's partnership.
|1||TECHNISCHE UNIVERSITEIT EINDHOVEN||NL (EINDHOVEN)||coordinator||766˙122.00|
|2||ASTRAZENECA AB||SE (SODERTAELJE)||participant||527˙318.00|
|3||UNIVERSITY OF DUNDEE||UK (DUNDEE)||participant||273˙287.00|
|4||UNIVERSITY OF LEEDS||UK (LEEDS)||participant||273˙287.00|
|5||CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS||FR (PARIS)||participant||262˙875.00|
|6||UNIVERSITA DEGLI STUDI DI SIENA||IT (SIENA)||participant||258˙061.00|
|7||CELLTECH R&D LIMITED||UK (SLOUGH)||participant||250˙513.00|
|8||LEAD DISCOVERY CENTER GMBH||DE (DORTMUND)||participant||249˙216.00|
|9||TAROS CHEMICALS GMBH & CO KG||DE (Dortmund)||participant||249˙216.00|
|10||UNIVERZITA KARLOVA||CZ (PRAHA 1)||participant||232˙422.00|
|11||UCB BIOPHARMA SRL||BE (BRUXELLES)||participant||0.00|
|12||GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD.||UK (BRENTFORD)||partner||0.00|
The goal of the TASPPI European Training Network (ETN) is the establishment of a highly interdisciplinary research and educational training platform for early stage scientists in the Chemical Life Sciences to overcome the inherent boundaries between academia and industry and to increase their employability in both areas. To this end we have teamed up in a consortium comprising 5 partners from industry (AstraZeneca, GlaxoSmithKline, UCB, Lead Disocvery Center, Taros Chemicals) and 6 partners from academia (Universities of Dundee, Eindhoven, Leeds, Lille, Prague, and Siena). The scientific objective of the multi-sectorial Training Network is the development and implementation of a multidisciplinary technology platform bringing together structural molecular biology, chemical biology, cell biology, synthetic chemistry, and medicinal chemistry for the identification of Small-molecule Stabilizers of Protein-Protein Interactions (PPIs) as a novel class of therapeutic agents and basic research tool compounds. With this new technological approach we aim to address a number of unmet medical needs in the areas Cancer, Neurodegenerative Diseases (Alzheimer’s, Parkinson’s), Pulmonary Diseases, Inflammation and Metabolic Diseases (Diabetes).
|Career Development Plan||Documents, reports||2020-04-07 20:06:56|
|Recruitment||Documents, reports||2020-04-07 20:06:56|
|Researcher Declaration||Documents, reports||2020-04-07 20:06:56|
Take a look to the deliverables list in detail: detailed list of TASPPI deliverables.
|year||authors and title||journal||last update|
Francesco Bosica, Sebastian Andrei, JoÃ£o Filipe Neves, Peter Brandt, Anders Gunnarsson, Isabelle Landrieu, Christian Ottmann, Gavin O\'Mahony
Design Of Drug-Like Protein-Protein Interaction Stabilizers Guided By Chelation-Controlled Bioactive Conformation Stabilization
published pages: , ISSN: 0947-6539, DOI: 10.1002/chem.202001608
|Chemistry - A European Journal||2020-04-24|
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "TASPPI" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (firstname.lastname@example.org) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "TASPPI" are provided by the European Opendata Portal: CORDIS opendata.
Big Data Challenges for MathematicsRead More
Training research pioneers by utilizing and validating the promise of electroporation for minimal invasive oncological treatments.Read More
Glyco-Nanoparticles for Applications in Advance NanomedicineRead More